Symposium on Dissolution Science to be Held in Haryana

This event aims to bring regulators, industry experts, and academics to one platform to discuss the innovations and challenges in dissolution science.

The Health Master

April 1, 2025

124

Symposium on Dissolution Science to be Held in Haryana

Table of Contents

Last Updated on April 3, 2025 by The Health Master

Dissolution Science

Haryana, India— The All India Pharmaceutical Associations Consortium (AIPAC), in collaboration with the following, is set to host a groundbreaking “Symposium on Dissolution Science and Drug Development:

Food and Drugs Administration (FDA), Haryana,
Haryana Pharmaceutical Manufacturers Association (HPMA),
Indian Pharmacopoeia Commission (IPC),
Society for Pharmaceutical Dissolution Science (SPDS),
National Institute of Pharmaceutical Education & Research (NIPER-SAS Nagar), and
Indian Drugs Manufacturers Association (IDMA).

Follow us on WhtasApp Channel

This event aims to bring regulators, industry experts, and academics to one platform to discuss the innovations and challenges in dissolution science, an important factor in the pharmaceutical sector.

The symposium, which will be held on April 26, 2025, will feature a lineup of distinguished speakers, including Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI), who will deliver the keynote address and serve as the chief guest.

Other notable attendees include Kamal Ranjan Chawla, State Drugs Controller, NCT of Delhi, as Guest of Honor, and Manmohan Taneja, State Drugs Controller, FDA Haryana, who will chair the event.

Agenda:

The inauguration ceremony of the whole-day symposium will start at 9:30 AM, followed by a series of technical sessions and panel discussions.

Key topics:

Innovations in Dissolution Apparatus:

Suhas Yewale, Associate Director at SOTAX India Pvt Ltd, will discuss the growing popularity of dissolution apparatus as per Indian Pharmacopoeia standards.

Regulatory Concerns:

Vijay Kshirsagar, Director & CEO of TRAC Pharma Consulting, will discuss the importance of dissolution in the pharmaceutical industry in compliance with regulatory requirements.

BCS Classification:

Prof. Sanyog Jain from NIPER-SAS Nagar will discuss how dissolution defines Biopharmaceutics Classification System (BCS) categories.

Challenges in Formulations:

Prof. Saranjit Singh, Ex-Professor at NIPER, will talk about issues like the cross-linking of gelatin in capsule dissolution.

Sudeep Ojha from Zydus Lifesciences Ltd. will shed light on the “coning” effect in tablet dissolution.

Pharma Digitalization:

Raveendranath Govindaraj, Founder of Lab Iconics Technologies LLP, will discuss how automation of laboratories enhances efficiency with respect to regulatory compliance.

Revised Schedule M:

R.K. Harna, ASDC (Retd.) FDA Haryana, will highlight the important points on updated Schedule M guidelines.

At the end of the symposium, a panel discussion will be moderated by Dr. Rajiv Desai, Senior Technical Advisor at IPA.

Panelists include:

Kamal Ranjan Chawla (SDC NCT of Delhi),
Dr. Ajay Sachan (DDC, CDSCO North Zone),
R.K. Harna, ASDC (Retd.) FDA Haryana and
Rakesh Dahiya (SDCO, Sonipat Zone, FDA Haryana).

Registration Details

The registration fee for the symposium is Rs. 500 + GST (Rs. 590). Delegates can register online at https://spds.in/registration/.

Importance of the Event

The symposium will provide a platform for regulators, industry experts, and academics to exchange knowledge on Revised Schedule M and dissolution science—an important factor in drug development and quality assurance—and address practical hurdles in formulation and compliance.

For more details, stay tuned to updates from AIPAC and its partnering organizations.

This event underscores Haryana’s growing role as a hub for pharmaceutical advancements in India.

Click below links for more articles on Revised Schedule M

Schedule M

Gist of 31 Chapters on Schedule M

Revised Schedule M Guidelines: Drug Recall and Ensuring Pharma Quality

Pharmaceutical Quality: Key Amendments in Revised Schedule M

Revised Schedule M: The Role of Pharmaceutical Waste Management

Guidance documents for industry

Key Notes on Revised Schedule M: Compilation

Also read

Counterfeit Drug Guidelines by Odisha